Supporting young patients through cancer treatment

Posted on Wednesday 11 December 2024

NICE reaches 1000th appraisal

Posted on Monday 23 September 2024

In September, the National Institute of Health and Care Excellence (NICE) reached a significant milestone by publishing its 1,000th Technology Appraisal, TA1000: Iptacopan for treating paroxysmal nocturnal haemoglobinuria.

New gene therapy for severe beta-thalassaemia

Posted on Thursday 19 September 2024

Research teams from the Centre for Reviews and Dissemination (CRD) and the Centre for Health Economics (CHE) assessed the clinical and cost-effectiveness of exagamglogene autotemcel for treating NHS patients with severe beta-thalassaemia.

Oral presentation at HEART UK Annual Conference

Posted on Wednesday 11 September 2024

CRD Research Fellow Alexis Llewellyn presented the results of a systematic review and network meta-analysis of lipid lowering therapies in children with heterozygous familial hypercholesterolaemia (HeFH) at the 2024 HEART UK Annual Conference held at the University of Warwick in July.

Prize winning Study Within a Review launched: Benefits and challenges of using machine learning technologies to prioritise screening in systematic reviews

Posted on Monday 22 July 2024

CRD researchers Sarah Nevitt, Rachel Churchill and Sofia Dias have launched a Study Within a Review (SWAR) to capture the experiences of systematic review teams using machine learning technologies to prioritise screening across a range of review projects.